A small percentage of patients taking GLP-1 medications have experienced vision problems, but a direct causal link with the ...

(RTTNews) - EyePoint Pharmaceuticals, Inc. (EYPT), Wednesday announced positive six-month results from the ongoing Phase 2 VERONA clinical trial, evaluating Duravyu for the treatment of diabetic ...

The World Health Organization reports that around 2.2 billion people struggle with vision problems such as near-sightedness ...

Genentech, a member of the Roche Group (RHHBY), announced that the U.S. Food and Drug Administration has approved Susvimo ...

The recall alert did not specify which type of fungi was found in the Systane eye drops, but many kinds of fungi can cause infection if they come in contact with the eyes or spread to the eyes from ...

Researchers have conducted one of the largest eye studies in the world to reveal new insights into retinal thickness, highlighting its potential in the early detection of diseases like type 2 diabetes ...